Jean-Claude Sirard Selected Research

Jean-Claude Sirard Research Topics

Disease

25	Infections 03/2024 - 02/2008
11	Pneumonia (Pneumonitis) 05/2024 - 10/2010
10	Inflammation (Inflammations) 03/2024 - 06/2009
6	Pneumococcal Infections 01/2022 - 08/2014
5	Superinfection 05/2024 - 01/2019
5	Bacterial Infections (Bacterial Infection) 10/2023 - 01/2020
4	Human Influenza (Influenza) 02/2024 - 02/2008
3	Pneumococcal Pneumonia 10/2023 - 01/2016
3	Colitis 01/2016 - 03/2007
2	Virus Diseases (Viral Diseases) 02/2024 - 01/2017
2	Whooping Cough (Pertussis) 01/2022 - 12/2019
2	Pseudomonas Infections 10/2021 - 01/2021
2	Acute Disease 05/2015 - 11/2010
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2024
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Lung Diseases (Lung Disease) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Bacterial Pneumonia 01/2021
1	Vaccine-Preventable Diseases 12/2019
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Atrophy 01/2018
1	Asthma (Bronchial Asthma) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2015
1	Plague (Bubonic Plague) 05/2013
1	Chronic Granulomatous Disease 01/2013
1	Diarrhea 01/2013
1	Bacteremia 01/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2013
1	Respiratory Syncytial Virus Infections 02/2008
1	Persistent Infection 08/2006

Drug/Important Bio-Agent (IBA)

12	FlagellinIBA 05/2024 - 06/2009
8	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 10/2015
6	Amoxicillin (Wymox)FDA LinkGeneric 05/2024 - 01/2019
6	Toll-Like Receptor 5IBA 05/2024 - 10/2015
6	CytokinesIBA 03/2024 - 08/2006
5	LigandsIBA 12/2023 - 02/2008
4	VaccinesIBA 02/2024 - 11/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 02/2008
3	ChemokinesIBA 01/2021 - 02/2008
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 05/2013
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2010
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 11/2010
2	Secretory Immunoglobulin A (SIgA)IBA 12/2019 - 09/2010
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 01/2016
2	Interleukin-22 (IL-22)IBA 01/2017 - 08/2014
2	AcidsIBA 01/2016 - 03/2007
1	AntigensIBA 02/2024
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2024
1	Meropenem (Merrem)FDA LinkGeneric 12/2023
1	LactamsIBA 01/2023
1	Attenuated VaccinesIBA 01/2022
1	SolutionsIBA 01/2022
1	Bacterial Proteins (Bacterial Protein)IBA 10/2021
1	InterleukinsIBA 01/2021
1	DNA Methyltransferase 3BIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	SmokeIBA 01/2021
1	Streptococcus pneumoniae plY proteinIBA 01/2021
1	monophosphoryl lipid AIBA 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	adjuvant system 01IBA 12/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2018
1	Interferon Type IIBA 10/2018
1	Hormones (Hormone)IBA 01/2018
1	Growth Hormone (Somatotropin)IBA 01/2018
1	AllergensIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2016
1	Interleukin-4 (Interleukin 4)IBA 05/2015
1	SuperantigensIBA 05/2015
1	Muramidase (Lysozyme)IBA 05/2013
1	Pattern Recognition ReceptorsIBA 01/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 04/2012
1	Polysaccharides (Glycans)IBA 04/2012
1	Immunoglobulin M (IgM)IBA 04/2012
1	Streptomycin (Streptomycin Sulfate)FDA Link 09/2010
1	NF-kappa B (NF-kB)IBA 02/2008
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2008

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2016
1	Intranasal Administration 03/2024
1	Immunomodulation 04/2021
1	Ligation 01/2016
1	Mucosal Administration 10/2010